Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.21 USD | +11.07% | -3.60% | -34.49% |
Feb. 15 | JPMorgan Adjusts Price Target on Adaptive Biotechnologies to $8 From $11, Maintains Overweight Rating | MT |
Feb. 15 | Adaptive Biotechnologies' Q4 Loss Widens; Revenue Declines; Shares Down | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.49% | 466M | |
+82.29% | 4.14B | |
-23.73% | 2.51B | |
-14.73% | 2.34B | |
-19.45% | 1.66B | |
+32.37% | 1.15B | |
+5.02% | 840M | |
-11.75% | 548M | |
+45.95% | 277M | |
-10.93% | 255M |
- Stock
- Equities
- Stock Adaptive Biotechnologies Corporation - Nasdaq
- News Adaptive Biotechnologies Corporation
- Adaptive Biotechnologies : Morgan Stanley Adjusts Adaptive Biotechnologies PT to $46 From $42, Maintains Equal Weight Rating